Topics: AI | Productivity | Science & Research | Startups | Venture Capital
Sam Rodriques, founder and CEO of Edison Scientific and Future House, explains how AI is already accelerating scientific discovery and drug development.
●
He shows why biology, not physics, remains the major unsolved frontier in science.
●
He breaks down how focused research organisations and AI agents remove the talent bottleneck.
●
He explains where AI helps most: verifiable tasks, high-throughput reasoning, and faster clinical development.
"The proof is in the pudding and the pudding is approved drugs." - Sam Rodriques